The venous oxygen saturation predicts the visual prognosis after anti‐VEGF treatment of central retinal vein occlusion

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Injury Following Intravitreal Anti-VEGF Administration in Diabetic Patients with Proliferative Diabetic Retinopathy and Chronic Kidney Disease - A Possible Side Effect?

By  

Current Drug Safety, Vol. 9, Iss. 2, 2014-07 ,pp. : 156-158

Bentham Science Publishers

Access to resources Recommend Favorite

Tomographic analysis of the retinal layers in diabetic macular edema treated with dexamethasone intravitreal implant

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors

By  

Current Drug Safety, Vol. 10, Iss. 2, 2015-07 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

Vitrectomy in treatment naive diabetic macular edema

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite